EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The CpG Island Methylator Phenotype Status in Synchronous and Solitary Primary Colorectal Cancers: Prognosis and Effective Therapeutic Drug Prediction

Yun-Yun Weng iD, Ming-Yii Huang iD

International Journal of Molecular Sciences · 11.05.2024 · 25 (10) · 5243

DOI: 10.3390/ijms25105243 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.05.2024. Verfasst von Yun-Yun Weng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, CpG Islands, DNA Methylation, Phenotype. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, R.O.C, Kaohsiung Medical University, Kaohsiung Medical University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synchronous colorectal cancer (sCRC) is characterized by the occurrence of more than one tumor within six months of detecting the first tumor. Evidence suggests that sCRC might be more common in the serrated neoplasia pathway, marked by the CpG island methylator phenotype (CIMP), than in the chromosomal instability pathway (CIN). An increasing number of studies propose that CIMP could serve as a potential epigenetic predictor or prognostic biomarker of sCRC. Therapeutic drugs already used for treating CIMP-positive colorectal cancers (CRCs) are reviewed and drug selections for sCRC patients are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCpG IslandsDNA MethylationPhenotypeHumansPrognosisBiomarkers, TumorEpigenesis, GeneticAntineoplastic Agents

Stichwörter der Autor:innen

CpG island methylator phenotypesynchronous colorectal cancerstherapeutic drug

Substanzen

Biomarkers, TumorAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Radiation Oncology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Department of Radiation Oncology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.

ORCID-Profile: Yun-Yun Weng, Ming-Yii Huang

Förderung

  • National Science and Technology Council, R.O.C
  • Kaohsiung Medical University
  • Kaohsiung Medical University Hospital
  • National Science and Technology Council, R.O.C.

Zitieren

APA

Weng, Y. Y., & Huang, M. Y. (2024). The CpG Island Methylator Phenotype Status in Synchronous and Solitary Primary Colorectal Cancers: Prognosis and Effective Therapeutic Drug Prediction. International Journal of Molecular Sciences, 25(10), 5243. https://doi.org/10.3390/ijms25105243

Vancouver

Weng YY, Huang MY. The CpG Island Methylator Phenotype Status in Synchronous and Solitary Primary Colorectal Cancers: Prognosis and Effective Therapeutic Drug Prediction. International Journal of Molecular Sciences. 2024;25(10):5243. doi:10.3390/ijms25105243

BibTeX
@article{Weng2024,
  author = {Weng, Yun-Yun and Huang, Ming-Yii},
  title = {The CpG Island Methylator Phenotype Status in Synchronous and Solitary Primary Colorectal Cancers: Prognosis and Effective Therapeutic Drug Prediction},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {10},
  pages = {5243},
  doi = {10.3390/ijms25105243}
}
Kostenlos starten →